Impact of haemostatic mechanisms on pathophysiology of preeclampsia

Chris Gardiner1, Manu Vatish2

  • 1Haemostasis Research Unit, Department of Haematology, University College London, United Kingdom.

Thrombosis Research
|March 7, 2017
PubMed

Insights

Preeclampsia, a pregnancy disorder, involves placental tissue factor and PAR-1. Understanding these may lead to new treatments for hypertension and proteinuria in pregnancy.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Research
  • Hematology

Background:

  • Preeclampsia (PE) is characterized by new-onset hypertension and proteinuria in late pregnancy.
  • Evidence suggests placental overexpression of tissue factor and PAR-1 contributes to PE pathophysiology.
  • Platelet, neutrophil, and complement system activation may also play a role in placental pathology and maternal endothelial dysfunction.

Purpose of the Study:

  • To explore the role of placental tissue factor and PAR-1 in preeclampsia.
  • To investigate the contribution of excessive cellular activation to PE pathology.
  • To identify potential new therapeutic targets for preeclampsia.

Main Methods:

  • Review of existing evidence on tissue factor and PAR-1 in PE.
  • Analysis of studies on platelet, neutrophil, and complement activation in PE.
  • Synthesis of findings to understand the pathophysiology of PE.

Main Results:

  • Placental overexpression of tissue factor and PAR-1 is increasingly implicated in PE.
  • Excessive activation of platelets, neutrophils, and the complement system are potential contributors to PE.
  • Current knowledge highlights complex interactions in PE development.

Conclusions:

  • Understanding the molecular mechanisms of PE, including tissue factor and PAR-1, is crucial.
  • Further research into cellular activation pathways may reveal novel therapeutic strategies.
  • Targeting placental and systemic inflammation could offer new treatment avenues for preeclampsia.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.3K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.2K